All posts tagged
Update: After 25 years, MorphoSys Gets its First Antibody Approved
With Actelion’s Acquisition Done, What are the Largest European Biotechs?
Update: MorphoSys Starts Phase III in Patients with Lymphoma
MorphoSys’ First Lanthipeptide Completes Phase I Successfully
Way to Success: What Role does Company Culture Play in Biotech?
Which EU Immuno-Oncology Company are you Cheering for?
Video Interview: How Morphosys Grew Into a Billion-Euro Biotech
What are the Best Countries to Recruit Biotech Talents in 2017?
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
Infographic: The Biggest Biotech Company in Each European Country
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II
Labiotech UG, All Rights Reserved -
Send this to a friend